Current Report Filing (8-k)
19 7월 2013 - 10:56PM
Edgar (US Regulatory)
United
States
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
---------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
July 15, 2013
China
Health Industries Holdings, Inc.
---------------------------------------
(Exact name of Company
as specified in charter)
Delaware |
|
000-51060 |
|
86-0827216 |
(State or other jurisdiction of Incorporation) |
|
(Commission File No.) |
|
(IRS Employer Identification No.) |
168 Binbei Street, Songbei District, Harbin
City
Heilongjiang Province, People’s Republic
of China 150028
(Address of principal executive
offices) (Zip Code)
Company’s telephone number,
including area code: 86-451-88100688
Check the appropriate box below if the Form 8-K filing
is intended to simultaneously satisfy the filing obligation of the Company under any of the following provisions:
¨ Written communications pursuant
to Rule 425 under the Securities Act (17CFR230.425)
¨ Soliciting material pursuant to
Rule14a-12 under the Exchange Act (17CFR240.14a-12)
¨ Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17CFR240.14d-2(b))
¨ Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17CFR240.13e-4(c))
Item 4.01. Changes in Registrant’s Certifying Accountant.
On July 15, 2013, China
Health Industries Holdings, Inc., a corporation incorporated under the laws of the State of Delaware (the “Company”)
dismissed De Joya Griffith & Company, LLC (“De Joya”) as the Company’s independent registered public
accounting firm. The decision to dismiss De Joya was approved by the Company’s sole director.
The principal accountant’s
report of De Joya on the financial statements of the Company as of and for the fiscal year ended June 30, 2011 did not contain
any adverse opinion or disclaimer of opinion and was not qualified or modified as to uncertainty, audit scope or accounting principles.
The Company’s audit for the fiscal year ended June 30, 2012 has not yet been commenced. De Joy was engaged by the Company
effective June 24, 2011.
During the Company’s
two most recent fiscal years and the subsequent interim period through July 15, 2013, there were no disagreements with De Joya
on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which if not
resolved to De Joya’s satisfaction would have caused it to make reference thereto in connection with its report. During the
Company’s two most recent fiscal years and the subsequent interim period through July 15, 2013, there were no reportable
events of the type described in Item 304(a)(1)(v) of Regulation S-K.
The Company provided
De Joya with a copy of the foregoing disclosure and requested De Joya to furnish the Company with a letter addressed to the Securities
and Exchange Commission stating whether it agrees with the statements made therein. A copy of such letter, dated July 18, 2013,
furnished by De Joya, is filed as Exhibit 16.1 to this Form 8-K.
On July 15, 2013, the
Company’s sole director approved the engagement of KCCW Accountancy Corp. (“KCCW”) as the Company’s
independent registered public accounting firm to audit its financial statements for the fiscal years ended June 30, 2013 and 2012.
During the Company’s
two most recent fiscal years and the subsequent interim period through July 15, 2013, neither the Company nor anyone on its behalf
consulted with KCCW regarding (i) the application of accounting principles to a specified transaction, either completed or proposed;
the type of audit opinion that might be rendered on the Company's financial statements, and neither a written report nor oral advice
was provided that KCCW concluded was an important factor considered by the Company in reaching a decision as to the accounting,
auditing or financial reporting issue; or (ii) any matter that was either the subject of a disagreement (as defined in Item 304(a)(1)(iv)
of Regulation S-K) or a reportable event (as described in Item 304(a)(1)(v) of Regulation S-K).
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
16.1 Letter from De Joya Griffith & Company, LLC dated
July 18, 2013
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Date: July 18, 2013
|
CHINA HEALTH INDUSTRIES HOLDINGS, INC. |
|
|
|
|
|
|
|
By: |
/s/ Xin Sun |
|
Name: |
Xin Sun |
|
Title: |
Chief Executive Officer and Chief Financial Officer |
China Health Industries (QB) (USOTC:CHHE)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
China Health Industries (QB) (USOTC:CHHE)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024